Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Postnatal Low Back Pain
Launched by CAIRO UNIVERSITY · May 19, 2024
Trial Information
Current as of July 15, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called modified lumbar Sustained Natural Apophyseal Glide to see if it helps reduce low back pain in women who have recently given birth. The researchers want to find out if this approach can provide relief for those experiencing chronic low back pain after having children.
To be eligible for this study, participants need to be women between the ages of 20 and 35 who have been diagnosed with chronic low back pain after childbirth and have had between 2 to 4 children. They also need to have a body mass index (BMI) of 30 or lower, which is a way to measure whether someone is a healthy weight. Women with certain back problems, skin issues, or other health conditions will not be able to participate. If you join the study, you can expect to receive this specific treatment method and contribute to research that could help other new mothers dealing with similar pain.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. All participants will be diagnosed as chronic postnatal low back pain.
- • 2. Their ages will be ranged from 20 to 35 years old.
- • 3. Their body mass index (BMI) will not exceed 30 kg/m2.
- • 4. All participants have the same social level.
- • 5. All participants have the same lifestyle.
- • 6. Their number of parity will be ranged from 2-4 children.
- Exclusion Criteria:
- • 1. Spinal fracture or any other neurological disorders.
- • 2. Lumbar spinal stenosis from lumbar disc herniation, degenerative joint diseases, or spondylolisthesis.
- • 3. Women with BMI \> 30 kg/m2.
- • 4. Participants who had pelvic pathology.
- • 5. Skin disease interferes with mobilization application.
- • 6. Gynecological diseases (chronic pelvic pain, uterine prolapse and retroversion flexion of the uterus).
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Azza Kassab, professor
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported